Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4

Status

Completed 3Unknown 2

Sponsor Class

NIH 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 5

Conditions

Sarcoma 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 8Liposarcoma 8Hemangiosarcoma 8Fibrosarcoma 8Lymphoma, Large B-Cell, Diffuse 7Sarcoma, Synovial 6Rhabdomyosarcoma 6Neurofibrosarcoma 6Malignant mesenchymal tumor 6Leukemia 6Leiomyosarcoma 6Histiocytoma, Malignant Fibrous 6Hemangiopericytoma, Malignant 6Testicular Neoplasms 5Teratoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Testicular Germ Cell Tumor 4Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Endodermal Sinus Tumor 4Seminoma 3Neuroblastoma 3Neoplasm Metastasis 3Lymphoma, Follicular 3Hodgkin Disease 3Carcinoma, Embryonal 3

Interventions

Carboplatin 190Cisplatin 156Pemetrexed 151Paclitaxel 127Docetaxel 109pembrolizumab 87Gemcitabine 73Erlotinib Hydrochloride 44Radiotherapy 39Vinorelbine 35Gefitinib 34durvalumab 31Bevacizumab 28Nivolumab 26Drug Therapy 23atezolizumab 22osimertinib 19130-nm albumin-bound paclitaxel 19tislelizumab 16Crizotinib 16Radiosurgery 15Etoposide 14Surgical Procedures, Operative 11Afatinib 11Ipilimumab 10icotinib 9aumolertinib 9Albumin-Bound Paclitaxel 9Specimen Handling 8Observation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Non-Small-Cell Lung × Ifosfamide × Clear all
NCT00003240 2013-12-18

Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
1,800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003159 2013-12-04

Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 3 Completed
600 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00004887 2013-09-20

Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery

National Cancer Institute (NCI)

Phase 3 Unknown
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00622349 2013-01-30

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

European Lung Cancer Working Party

Phase 3 Completed
707 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00148395 2008-04-22

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

Aktion Bronchialkarzinom e.V.

Phase 3 Completed
280 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡